INTERCEPT PHARMACEUTICALS IN
(45845PAB4)
ファンドの報告 INTERCEPT PHARMACEUTICALS IN 13F提出書類による
商号 | 保有株式/元本 | 市場価格 | オプション | 報告期間 | 有効日 |
---|---|---|---|---|---|
Linden Advisors LP | 28,527,000 | $28,380k | Jun 30, 2019 | Aug 14, 2019 | |
Highbridge Capital Management LLC | 20,000,000 | $19,894k | Jun 30, 2019 | Aug 14, 2019 | |
Graham Capital Management LP | 10,650,000 | $10,579k | Jun 30, 2019 | Aug 14, 2019 | |
Senvest Management LLC | 5,000,000 | $4,998k | Jun 30, 2019 | Aug 13, 2019 | |
Gabelli & Company Investment Advisers Inc | 300,000 | $300k | Jun 30, 2019 | Aug 2, 2019 |